Rx News Connection: March 2021

  Price  

  Credits  

-

This product is currently out of stock and unavailable.


Format

In the medical arena, information changes quickly. What was irrelevant yesterday, may be paramount today. PharmCon’s News Connection series seeks to distill the most impactful news for health professionals from the vast sea of news that confronts us all, then bridge the gap between the immediacy of those critical items and the delay that occurs as that information is incorporated into more focused programming. Our team of skilled editors continually scans the emerging medical news to bring the most relevant pieces to the forefront and deliver them to you in a concise, practical manner. In this session, we investigate timely items, including: COVID-19 Vaccine Interim Updates, Combo Monoclonal Antibody Treatment Gets EUA for Mild-to-Moderate COVID-19, Semaglutide is Effective for Weight Loss, SGLT2 Inhibitors Linked to DKA in COVID Patients with Diabetes, Erenumab ( Aimovig®) Increases BP, Antidepressants Used for Low Back Pain Likely Not Helpful. 

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharmacist

Nurse

Pharmacy Technician

Author

James Chan
PharmD, PhD
Cherie Dillon
Associate Editor
James Chan
PharmD, PhD
Cherie Dillon
Associate Editor
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Describe the risk of using erenumab in a patient who has high blood pressure.

State the indication for monoclonal antibody treatments that have received FDA authorization for use in patients with COVID-19.

Discuss the use of semaglutide for weight loss in people who are overweight or obese.

Discuss recent drug approvals, updated drug therapy recommendations, and important clinical trial results that may have an impact on today's practitioners and patients.

Pharmacist

Pharmacist

  • Discuss recent drug approvals, updated drug therapy recommendations, and important clinical trial results that may have an impact on today's practitioners and patients.
  • State the indication for monoclonal antibody treatments that have received FDA authorization for use in patients with COVID- 19.
  • Discuss the use of semaglutide for weight loss in people who are overweight or obese.
  • Describe the risk of using erenumab in a patient who has high blood pressure.

Nurse

Nurse

  • Discuss recent drug approvals, updated drug therapy recommendations, and important clinical trial results that may have an impact on today's practitioners and patients.
  • State the indication for monoclonal antibody treatments that have received FDA authorization for use in patients with COVID- 19.
  • Discuss the use of semaglutide for weight loss in people who are overweight or obese.
  • Describe the risk of using erenumab in a patient who has high blood pressure.

Pharmacy Technician

Pharmacy Technician

  • Discuss recent drug approvals, updated drug therapy recommendations, and important clinical trial results that may have an impact on today's practitioners and patients.
  • State the indication for monoclonal antibody treatments that have received FDA authorization for use in patients with COVID- 19.
  • Discuss the use of semaglutide for weight loss in people who are overweight or obese.
  • Describe the risk of using erenumab in a patient who has high blood pressure.

Course Accreditation

  • Activity Type:
    Application
  • Financial Support By:
    PharmCon
  • CE Broker
    870784
  • Universal Activity Number:
    Nurse : 0798-9999-21-162-H01-N
    Pharmacy Technician : 0798-9999-21-162-H01-T
    Pharmacist : 0798-9999-21-162-H01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

Credit for this program is issued by passing the final test hosted at www.RxConsultant.com with a score of 70% or higher.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.